levacetylleucine (Aqneursa)
Jump to navigation
Jump to search
Indications
Dosage
- oral suspension
- one gram individual dose packet mixed in 40 mL of water, orange juice, or almond milk if taken by mouth
- mixed with water only if given through a G-tube
- administered orally up to three times daily with or without food
- dosage based on a patient's weight
Adverse effects
- abdominal pain, dysphagia, upper respiratory tract infections, vomiting
Mechanism of action
- unknown
More general terms
References
- ↑ Monaco K Second Drug OK'd for Ultra-Rare Neurodegenerative Disease. FDA approves levacetylleucine (Aqneursa) for Niemann-Pick disease type C. MedPage Today September 25, 2024 https://www.medpagetoday.com/genetics/generalgenetics/112111